Terms: = Pancreatic cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
110 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the PI3K/akt signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
3. NUDT21 interacts with NDUFS2 to activate the PI3K/akt pathway and promotes pancreatic cancer pathogenesis.
Huang XD; Chen YW; Tian L; Du L; Cheng XC; Lu YX; Lin DD; Xiao FJ
J Cancer Res Clin Oncol; 2024 Jan; 150(1):8. PubMed ID: 38195952
[TBL] [Abstract] [Full Text] [Related]
4. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
5. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study.
Kurita Y; Kubota K; Fujita Y; Tsujino S; Sekino Y; Kasuga N; Iwasaki A; Iwase M; Izuka T; Kagawa K; Tanida E; Yagi S; Hasegawa S; Sato T; Hosono K; Kobayashi N; Ichikawa Y; Nakajima A; Endo I
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):173-182. PubMed ID: 38124014
[TBL] [Abstract] [Full Text] [Related]
6. Risk of Type 1 Diabetes Mellitus in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study.
Li MC; Wu CY; Chang YT; Lyu YS; Wu CY
Dermatology; 2024; 240(2):254-261. PubMed ID: 38118430
[TBL] [Abstract] [Full Text] [Related]
7. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
8. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract] [Full Text] [Related]
9. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study.
Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K
BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334
[TBL] [Abstract] [Full Text] [Related]
10. The Link between Diabetes, pancreatic Tumors, and miRNAs-New Players for diagnosis and Therapy?
Kozłowska M; Śliwińska A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373398
[TBL] [Abstract] [Full Text] [Related]
11. Emerging roles of long non-coding RNA FTX in human disorders.
Sheykhi-Sabzehpoush M; Ghasemian M; Khojasteh Pour F; Mighani M; Moghanibashi M; Mohammad Jafari R; Zabel M; Dzięgiel P; Farzaneh M; Kempisty B
Clin Transl Oncol; 2023 Oct; 25(10):2812-2831. PubMed ID: 37095425
[TBL] [Abstract] [Full Text] [Related]
12. Crosstalk between circRNAs and the PI3K/akt and/or MEK/ERK signaling pathways in digestive tract malignancy progression.
Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
[TBL] [Abstract] [Full Text] [Related]
13. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/akt/mTOR pathway.
Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z
Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of the safety and diagnostic efficiency of CT-guided percutaneous biopsy of pancreatic space-occupying lesions using large needle:comparison of trans-organ biopsy approach and non-trans-organ biopsy approach].
Wang M; Zhou ZG; Du KP; Li S; Li YD; Gao F; Gao MY; Gao JB
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(5):364-369. PubMed ID: 36740395
[No Abstract] [Full Text] [Related]
15. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review.
Farasati Far B; Vakili K; Fathi M; Yaghoobpoor S; Bhia M; Naimi-Jamal MR
Life Sci; 2023 Mar; 316():121340. PubMed ID: 36586571
[TBL] [Abstract] [Full Text] [Related]
16. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica.
Liu Z; Hong LL; Zheng JS; Ling ZN; Zhang ZL; Qi YN; Zhang XY; Zhu TY; Wang JL; Han J; Chen XL; Yu QM; Wang S; Li P; Ling ZQ
Gastric Cancer; 2023 Mar; 26(2):203-219. PubMed ID: 36450891
[TBL] [Abstract] [Full Text] [Related]
18. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating akt signaling pathway.
Zhang Z; Yu H; Yao W; Zhu N; Miao R; Liu Z; Song X; Xue C; Cai C; Cheng M; Lin K; Qi D
Cell Commun Signal; 2022 Nov; 20(1):188. PubMed ID: 36434608
[TBL] [Abstract] [Full Text] [Related]
19. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
20. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-akt signaling pathway.
Wu W; Li Q; Zhu Z; Li C; Lu P; Zhou X; Huang Y; Liu Y; Wang M; Gong J
Int J Biol Sci; 2022; 18(9):3777-3794. PubMed ID: 35813473
[TBL] [Abstract] [Full Text] [Related]
[Next]
